Control of HIV-1 infection by soluble factors of the immune response (Q35752416)

10 August 2017

1 reference

title

Control of HIV-1 infection by soluble factors of the immune response (English)

1 reference

10 August 2017

2

Robert C Gallo

1 reference

10 August 2017

1

Anthony L DeVico

1 reference

PubMed ID

15100693

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Nature Reviews Microbiology

10 August 2017

1 reference

10 August 2017

2

1 reference

10 August 2017

5

1 reference

10 August 2017

401-413

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro878

10 August 2017

0 references

cites work

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

NK cells and NKT cells in innate defense against viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Viruses and interferon: a fight for supremacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Exquisite specificity of adoptive immunization in arenavirus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Inhibition of HIV-1 infection by the beta-chemokine MDC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Dichotomous effects of macrophage-derived chemokine on HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

T cell-derived suppressive activity: evidence of autocrine noncytolytic control of HIV type 1 transcription and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV suppression by interleukin-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Why listeriosis? A perspective on cellular immunity to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Retraction of an Interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Chemokine receptors and chemokines in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV infection and pathogenesis: what about chemokines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The role of chemokines in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Modulating influence on HIV/AIDS by interacting RANTES gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

C-C chemokines, pivotal in protection against HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Decrease in human immunodeficiency virus type 1 load during acute dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV-1 suppression during acute scrub-typhus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Infection with GB virus C and reduced mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

GB virus-C infection in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Regulation of CC chemokine receptor 5 in hepatitis G virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of human immunodeficiency virus replication during acute measles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

In vitro correlates of HIV-2-mediated HIV-1 protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV preferentially infects HIV-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ cells from HIV-2-infected baboons control HIV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator Inhibits HIV-1 Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Gamma/delta T lymphocytes in viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

An overview of the interferon system: signal transduction and mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Double infections with hepatitis A and B viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ cell anti-HIV activity: nonlytic suppression of virus replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Recombinant human interferon gamma suppresses HTLV-III replication in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

The role of interferons in the control of HIV replication in macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Role of IL-16 in HIV replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Defensins inhibit HIV replication in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T cells is dependent on the NFAT-1 element

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Passive transfer of scrub typhus plasma to patients with AIDS: a descriptive clinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Spontaneous production of RANTES and antigen-specific IFN-gamma production in macaques vaccinated with SHIV-4 correlates with protection against SIVsm challenge

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

7 January 2021

Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

7 January 2021

Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

7 January 2021

https://api.crossref.org/works/10.1038%2FNRMICRO878

1 reference

7 January 2021

Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

7 January 2021

Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO878

7 January 2021

Identifiers

DOI

10.1038/NRMICRO878

1 reference

10 August 2017

1 reference

PubMed ID

15100693